๐ Our ATRO Medical share funding campaign gives informal investors, meniscus patients and orthopedic surgeons the opportunity to join us on our journey. And reap the benefits once when we hit the market. ๐ค
๐ Discover the campaign here:
lnkd.in/dMu6rGzu
Support, shares, and introductions within your network are hugely appreciated. ๐๐จ๐ฎ๐ซ ๐ฉ๐๐ซ๐ฌ๐จ๐ง๐๐ฅ ๐ซ๐๐๐จ๐ฆ๐ฆ๐๐ง๐๐๐ญ๐ข๐จ๐ง ๐ญ๐ซ๐ฎ๐ฅ๐ฒ ๐ฆ๐๐ญ๐ญ๐๐ซ๐ฌ!
Letโs build the meniscus innovation of the decade. Together.
And before we run out... get your share now! โฉ
#sharefunding #medtech #meniscus #crowdfunding #investing #Eyevestor
Investment
Next milestone for ATRO Medical!
The FDA has confirmed ๐๐ซ๐๐๐ค๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก ๐๐๐ฏ๐ข๐๐ ๐๐๐ฌ๐ข๐ ๐ง๐๐ญ๐ข๐จ๐ง for the ๐ฅ๐๐ญ๐๐ซ๐๐ฅ Artimisยฎ Meniscus Prosthesis.
This means ATRO Medical is now the ๐๐ข๐ซ๐ฌ๐ญ ๐๐จ๐ฆ๐ฉ๐๐ง๐ฒ ๐ฐ๐จ๐ซ๐ฅ๐๐ฐ๐ข๐๐ with:
โ
FDA Breakthrough Device Designations
โ
Award-winning product designs
โ
Ongoing clinical research
for both ๐๐๐๐ข๐๐ฅ ๐๐ง๐ ๐๐๐ญ๐๐ซ๐๐ฅ meniscus replacements.
The Artimis Meniscus Prosthesis is for only research use in Europe for now. But these achievements mark our steps toward new treatment options for patients suffering from post-meniscectomy pain worldwide.
Investment